Jessica Garcia/LinkedIn
Jul 13, 2026, 18:42
Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
Jessica Garcia, Pediatric Hematologist, Hemostasis and Thrombosis Specialist at UT Southwestern Medical Center, shared a post on LinkedIn:
“Honored to present at International Society on Thrombosis and Haemostasis (ISTH) this year in Paris.
Our poster highlighted thrombin generation patterns in a patient with type 3 VWD with inhibitor on emicizumab prophylaxis, including both in vitro spiking with recombinant FVIIa and in vivo peri‑operative data.
A great discussion on how global assays can capture (and sometimes challenge) what we expect clinically.”
More posts featuring Jessica Garcia on Hemostasis Today.
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
-
Aug 13, 2026, 08:11Cristiana Coneru: How the Gut Microbiome Influences Venous Thrombosis
-
Aug 13, 2026, 06:36Steffen Uffenorde: Improving Access to Automated Red Cell Exchange in SCD